DrugPatentWatch Database Preview

Details for Patent: 8,343,130

Which drugs does patent 8,343,130 protect, and when does it expire?

Patent 8,343,130 protects SUMAVEL DOSEPRO and is included in one NDA.

This patent has nine patent family members in six countries.

Summary for Patent: 8,343,130

Title:	Needleless injector
Abstract:	A needleless injector has a syringe body having an opening at one end, a piston housed within the syringe body for urging a liquid within the syringe body through the opening and a ram for driving the piston. A shock absorbing component is provided for reducing an initial transfer of force from the ram to the piston. The initial rate of pressure increase on the liquid is reduced, thereby controlling the rate of collapse of gas bubbles in the liquid.
Inventor(s):	Green; Terry (Norfolk, GB)
Assignee:	Zogenix, Inc. (Emeryville, CA)
Application Number:	13/088,140
Patent Claim Types: see list of patent claims	Use; Dosage form; Delivery; Formulation;

Drugs Protected by US Patent 8,343,130

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Endo Ventures Ltd	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009		DISCN	Yes	No	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Foreign Priority and PCT Information for Patent: 8,343,130

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0125506.6	Oct 24, 2001

Non-Orange Book US Patents Family Members for Patent 8,343,130

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
9,629,960	Needleless injector	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Family Members for US Patent 8,343,130

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2464459	➤ Sign Up
Germany	60214870	➤ Sign Up
European Patent Office	1439872	➤ Sign Up
United Kingdom	0125506	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 8,343,130

Foreign Priority and PCT Information for Patent: 8,343,130

For more information try a trial or see the plans and pricing